Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference

  Anavex Life Sciences to Present at the 2019 BIO CEO & Investor Conference NEW YORK – February 4, 2019 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other…